<DOC>
	<DOCNO>NCT00437710</DOCNO>
	<brief_summary>We study prospective randomise fashion 50 patient treat intracoronary transplantation autologous , mononuclear bone marrow cell ( BMCs ) addition standard therapy MI standard therapy . After standard therapy acute MI , 10 patient transplant autologous mononuclear BMCs via balloon catheter place infarct-related artery balloon dilatation ( percutaneous transluminal coronary angioplasty ) . Another 10 patient acute MI treat standard therapy alone . After</brief_summary>
	<brief_title>Safety Efficacy Bone Marrow Cell Transplantation Humans Myocardial Infarction</brief_title>
	<detailed_description>Experimental clinical data suggest bone marrow-derived cell may contribute heal myocardial infarction ( MI ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Recent acute transmural anterior myocardial infarction , ( agreement WHO ) single leave anterior descend coronary artery disease &lt; 72 hour origin symptom successful primary angioplasty culprit lesion screen &gt; 72 hour infarction , cardiac shock , severe comorbidity , alcohol drug dependency severe comorbidity ( DM , renal liver insufficiency ) potential child bear woman inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>bone marrow , cell transplantation , stem cell , PTCA</keyword>
</DOC>